Colorectal Cancer Therapeutics Market 2020: Emerging Technologies, Revenue, Analysis, Opportunity Assessment and Strateg

1. Colorectal Cancer Therapeutics Market Size, Share & Industry Analysis, By Therapy (Targeted Therapy, Immunotherapy, Chemotherapy, Others), By Cancer Type (Colorectal Adenocarcinoma, Gastrointestinal Carcinoid Tumors, Others), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and Regional Forecast, 2019-2026 Buy Now Sample PDF Get Discount Published Date: April 2019 Region: Global Report Format: PDF Base Year: 2018 Fortune Business Insights Pvt Ltd.

2. Colorectal Cancer Therapeutics Market Size, Share & Industry Analysis, By Therapy (Targeted Therapy, Immunotherapy, Chemotherapy, Others), By Cancer Type (Colorectal Adenocarcinoma, Gastrointestinal Carcinoid Tumors, Others), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and Regional Forecast, 2019-2026 Report Highlights: The global colorectal cancer therapeutics market size is projected to reach USD 16.58 billion by 2026, owing to the rise in the prevalence of colorectal cancer worldwide. A report by Fortune Business Insights™ titled, “Colorectal Cancer Therapeutics Market Size, Share & Industry Analysis, By Therapy (Targeted Therapy, Immunotherapy, Chemotherapy, Others), By Cancer Type (Colorectal Adenocarcinoma, Gastrointestinal Carcinoid Tumors, Others), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and Regional Forecast, 2019-2026,” provides a detailed analysis of the same. According to the report, the colorectal cancer drugs market was valued at USD 9.26 billion in 2018. The forecast period is set from 2019 to 2026, and the market is likely to exhibit a CAGR of 7.6%. As per current colorectal cancer therapeutics market trends, the targeted therapy segment is dominating the market in terms of therapy. This is attributed to the presence of a large number of prominent targeted cancer therapies such as Stivarga, Erbitux, and Avastin. Fortune Business Insights Pvt Ltd.

3. Colorectal Cancer Therapeutics Market Size, Share & Industry Analysis, By Therapy (Targeted Therapy, Immunotherapy, Chemotherapy, Others), By Cancer Type (Colorectal Adenocarcinoma, Gastrointestinal Carcinoid Tumors, Others), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and Regional Forecast, 2019-2026 Launch of Better Therapeutics for Colorectal Cancer to Aid in Expansion of Market The rise in awareness about colorectal cancer is a major factor driving the colorectal cancer therapeutics market growth. Additionally, the increasing number of corresponding product launches for effective colorectal cancer treatment is further expected to help increase the overall market growth in the forecast period. Moreover, the advent of the latest initiatives aiming to provide effective care of colorectal cancer patients is more likely to aid in the expansion of the market for colorectal cancer drugs. Furthermore, the high mortality rates, coupled with the rising demand for effective cancer therapeutics worldwide, is prognosticated to have a positive effect on the colorectal cancer medications market size in the forthcoming years. Rise in Disposable Incomes and Increasing Awareness about Therapeutic Procedures to Help Asia Pacific Witness Rapid Growth Geographically, North America is leading the market with a high prevalence of colorectal cancer. In 2018, North America earned USD 4.13 billion, owing to the new product launches in and around the region. Thus, the factors mentioned above are likely to help this region continue dominating the market in the future too. Browse Complete Report Details: https://www.fortunebusinessinsights.com/industry-reports/colorectal-cancer-therapeutics-market- 101945 Fortune Business Insights Pvt Ltd.

4. Colorectal Cancer Therapeutics Market Size, Share & Industry Analysis, By Therapy (Targeted Therapy, Immunotherapy, Chemotherapy, Others), By Cancer Type (Colorectal Adenocarcinoma, Gastrointestinal Carcinoid Tumors, Others), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and Regional Forecast, 2019-2026 List of the companies functioning in the global market are: • Novartis AG • Bayer AG • Merck Sharp & Dohme Corp. • Bristol Myers Squibb • Pfizer Inc. • Genentech, Inc. • Ipsen Biopharmaceuticals, Inc. • Regeneron Pharmaceuticals, Inc. • Taiho Pharmaceutical (Otsuka Pharmaceutical Co., Ltd.) • Sanofi • Teva Pharmaceutical Industries Ltd. Eli Lilly and Company Get Customization: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/colorectal-cancer-therapeutics- market-101945 Fortune Business Insights Pvt Ltd.

5. Colorectal Cancer Therapeutics Market Size, Share & Industry Analysis, By Therapy (Targeted Therapy, Immunotherapy, Chemotherapy, Others), By Cancer Type (Colorectal Adenocarcinoma, Gastrointestinal Carcinoid Tumors, Others), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and Regional Forecast, 2019-2026 About Us: Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in. Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data. Phone: US: +1 424 253 0390 UK: +44 2071 939123 APAC: +91 744 740 1245 Email: sales@fortunebusinessinsights.com Fortune Business Insights Pvt Ltd.